These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 30413614

  • 1. Association between three genetic variants in kallikrein 3 and prostate cancer risk.
    Ding WH, Ren KW, Yue C, Zou JG, Zuo L, Zhang LF, Bai Y, Okada A, Yasui T, Mi YY.
    Biosci Rep; 2018 Dec 21; 38(6):. PubMed ID: 30413614
    [Abstract] [Full Text] [Related]

  • 2. Association of gene polymorphisms of KLK3 and prostate cancer: A meta-analysis.
    Li H, Fei X, Shen Y, Wu Z.
    Adv Clin Exp Med; 2020 Aug 21; 29(8):1001-1009. PubMed ID: 32869960
    [Abstract] [Full Text] [Related]

  • 3. Single-nucleotide polymorphism rs1058205 of KLK3 is associated with the risk of prostate cancer: A case-control study of Han Chinese men in Northeast China.
    Chen C, Xin Z.
    Medicine (Baltimore); 2017 Mar 21; 96(10):e6280. PubMed ID: 28272245
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels.
    Penney KL, Schumacher FR, Kraft P, Mucci LA, Sesso HD, Ma J, Niu Y, Cheong JK, Hunter DJ, Stampfer MJ, Hsu SI.
    Carcinogenesis; 2011 Jun 21; 32(6):853-9. PubMed ID: 21421545
    [Abstract] [Full Text] [Related]

  • 11. KLK3 SNP-SNP interactions for prediction of prostate cancer aggressiveness.
    Lin HY, Huang PY, Cheng CH, Tung HY, Fang Z, Berglund AE, Chen A, French-Kwawu J, Harris D, Pow-Sang J, Yamoah K, Cleveland JL, Awasthi S, Rounbehler RJ, Gerke T, Dhillon J, Eeles R, Kote-Jarai Z, Muir K, UKGPCS collaborators, Schleutker J, Pashayan N, APCB (Australian Prostate Cancer BioResource), Neal DE, Nielsen SF, Nordestgaard BG, Gronberg H, Wiklund F, Giles GG, Haiman CA, Travis RC, Stanford JL, Kibel AS, Cybulski C, Khaw KT, Maier C, Thibodeau SN, Teixeira MR, Cannon-Albright L, Brenner H, Kaneva R, Pandha H, PRACTICAL consortium, Srinivasan S, Clements J, Batra J, Park JY.
    Sci Rep; 2021 Apr 29; 11(1):9264. PubMed ID: 33927218
    [Abstract] [Full Text] [Related]

  • 12. Association study between common variations in some candidate genes and prostate adenocarcinoma predisposition through multi-stage approach in Iranian population.
    Beikzadeh B, Angaji SA, Abolhasani M.
    BMC Med Genet; 2020 Apr 15; 21(1):81. PubMed ID: 32295536
    [Abstract] [Full Text] [Related]

  • 13. The association between three AXIN2 variants and cancer risk.
    Dai F, Zhu LJ, Zhang W, Mi YY, Sun HY, Zhang LF, Yue C, Wu XY, Zuo L, Bai Y.
    J Cell Biochem; 2019 Sep 15; 120(9):15561-15571. PubMed ID: 31038806
    [Abstract] [Full Text] [Related]

  • 14. Association between RNASEL, MSR1, and ELAC2 single nucleotide polymorphisms and gene expression in prostate cancer risk.
    Alvarez-Cubero MJ, Pascual-Geler M, Martinez-Gonzalez LJ, Expósito Ruiz M, Saiz M, Cozar JM, Lorente JA.
    Urol Oncol; 2016 Oct 15; 34(10):431.e1-8. PubMed ID: 27318894
    [Abstract] [Full Text] [Related]

  • 15. The Association Between Three Genetic Variants in MicroRNAs (Rs11614913, Rs2910164, Rs3746444) and Prostate Cancer Risk.
    Mi Y, Ren K, Zou J, Bai Y, Zhang L, Zuo L, Okada A, Yasui T.
    Cell Physiol Biochem; 2018 Oct 15; 48(1):149-157. PubMed ID: 30001553
    [Abstract] [Full Text] [Related]

  • 16. Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels.
    Parikh H, Wang Z, Pettigrew KA, Jia J, Daugherty S, Yeager M, Jacobs KB, Hutchinson A, Burdett L, Cullen M, Qi L, Boland J, Collins I, Albert TJ, Vatten LJ, Hveem K, Njølstad I, Cancel-Tassin G, Cussenot O, Valeri A, Virtamo J, Thun MJ, Feigelson HS, Diver WR, Chatterjee N, Thomas G, Albanes D, Chanock SJ, Hunter DJ, Hoover R, Hayes RB, Berndt SI, Sampson J, Amundadottir L.
    Hum Genet; 2011 Jun 15; 129(6):675-85. PubMed ID: 21318478
    [Abstract] [Full Text] [Related]

  • 17. Association between the 8q24 rs6983267 T/G polymorphism and prostate cancer risk: a meta-analysis.
    Zhu HS, Zhang JF, Zhou JD, Zhang MJ, Hu HX.
    Genet Mol Res; 2015 Dec 29; 14(4):19329-41. PubMed ID: 26782586
    [Abstract] [Full Text] [Related]

  • 18. Association of Hsa-miR-23a rs3745453 variation with prostate cancer risk among Chinese Han population: A case-control study.
    Zhang M, Wang Y, Wang C, You Z, Chen S, Kong Q, Xu B, Liu C, Chen M.
    Medicine (Baltimore); 2019 Dec 29; 98(52):e18523. PubMed ID: 31876746
    [Abstract] [Full Text] [Related]

  • 19. A comprehensive resequence analysis of the KLK15-KLK3-KLK2 locus on chromosome 19q13.33.
    Parikh H, Deng Z, Yeager M, Boland J, Matthews C, Jia J, Collins I, White A, Burdett L, Hutchinson A, Qi L, Bacior JA, Lonsberry V, Rodesch MJ, Jeddeloh JA, Albert TJ, Halvensleben HA, Harkins TT, Ahn J, Berndt SI, Chatterjee N, Hoover R, Thomas G, Hunter DJ, Hayes RB, Chanock SJ, Amundadottir L.
    Hum Genet; 2010 Jan 29; 127(1):91-9. PubMed ID: 19823874
    [Abstract] [Full Text] [Related]

  • 20. Genetic variation in KLK2 and KLK3 is associated with concentrations of hK2 and PSA in serum and seminal plasma in young men.
    Sävblom C, Halldén C, Cronin AM, Säll T, Savage C, Vertosick EA, Klein RJ, Giwercman A, Lilja H.
    Clin Chem; 2014 Mar 29; 60(3):490-9. PubMed ID: 24270797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.